These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 458598)

  • 1. Prostaglandin prodrugs. I: Stabilization of dinoprostone (prostaglandin E2) in solid state through formation of crystalline C1-phenyl esters.
    Morozowich W; Oesterling TO; Miller WL; Lawson CF; Weeks JR; Stehle RG; Douglas SL
    J Pharm Sci; 1979 Jul; 68(7):833-6. PubMed ID: 458598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin prodrugs. 5.1 Prostaglandin E2 ethylene ketal.
    Cho MJ; Bundy GL; Biermacher JJ
    J Med Chem; 1977 Nov; 20(11):1525-7. PubMed ID: 410931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin prodrugs. II: New method for synthesizing prostaglandin C1-aliphatic esters.
    Morozowich W; Oesterling TO; Miller WL; Douglas SL
    J Pharm Sci; 1979 Jul; 68(7):836-8. PubMed ID: 458599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of some prostaglandin E1 and omega-homo-prostaglandin E1 esters and their inhibiting properties on rat blood platelet aggregation.
    van der Wolf L; Kloeze J; Pabon HJ; van Dorp DA
    Prostaglandins; 1978 May; 15(5):795-801. PubMed ID: 704904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins V (1). Synthesis and pharmacology of (+/-)-11-deoxy-10-hydroxyprostaglandin E1 methyl ester.
    Caton MP; Darnbrough G; Hambling DJ; Jordon R; Parker T
    Prostaglandins; 1979 Oct; 18(4):569-76. PubMed ID: 531225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 10-oxa-11-deoxyprostaglandin E1 and 10-nor-9,11-secoprostaglandin F1 and their derivatives.
    Carroll FI; Hauser FM; Huffman RC; Coleman MC
    J Med Chem; 1978 Apr; 21(4):321-5. PubMed ID: 650661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE(1) and 9-beta-halo derivatives with improved stability.
    Maruyama T; Asada M; Shiraishi T; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Jun; 10(6):1743-59. PubMed ID: 11937333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of γ-lactam analogs of PGE₂ as EP4 and EP2/EP4 agonists.
    Kambe T; Maruyama T; Nakai Y; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
    Bioorg Med Chem; 2012 Jun; 20(11):3502-22. PubMed ID: 22546206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal and cardiovascular effects of the prostaglandin analogue Hoe 260.
    Bickel M; Bartmann W; Beck G; Lerch U; Schleyerbach R; Schölkens BA
    Biomed Biochim Acta; 1984; 43(8-9):S235-8. PubMed ID: 6596097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and congeners, 29. (16RS)-(+/-)-15-Deoxy-16-hydroxy-16-vinyl-prostaglandin E2, an orally and transdermally active hypotensive agent of prolonged duration.
    Birnbaum JE; Cervoni P; Chan PS; Chen SM; Floyd MB; Grudzinskas CV; Weiss J; Dessy F
    J Med Chem; 1982 May; 25(5):492-4. PubMed ID: 7086833
    [No Abstract]   [Full Text] [Related]  

  • 11. Properties of prostaglandin derivatives on a phospholipid basis.
    Lekim D; Sieck A; Betzing H; Kunze H
    Adv Prostaglandin Thromboxane Res; 1978; 3():193-8. PubMed ID: 655006
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biological activity of 9-deoxo-9-methylene and related prostaglandins.
    Bundy GL; Kimball FA; Robert A; Aiken JW; Maxey KM; Sebek OK; Nelson NA; Sih JC; Miller WL; Hsi RS
    Adv Prostaglandin Thromboxane Res; 1980; 6():355-63. PubMed ID: 7386275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin prodrugs III: Synthesis and biological properties of C9- and C15-monoesters of dinoprost (prostaglandin F2 alpha).
    Morozowich W; Oesterling TO; Miller WL; Lawson CF; Cornette JC; Weeks JR; Douglas SL
    J Pharm Sci; 1979 Aug; 68(8):949-51. PubMed ID: 113524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative aqueous stabilities of dinoprostone free acid (prostaglandin E2) and its carbamoylmethyl ester.
    Stehle RG; Smith RW
    J Pharm Sci; 1976 Dec; 65(12):1844-5. PubMed ID: 25956
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and biological activity of prostaglandin lactones.
    Bundy GL; Peterson DC; Cornette JC; Miller WL; Spilman CH; Wilks JW
    J Med Chem; 1983 Aug; 26(8):1089-99. PubMed ID: 6876076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin prodrugs IV; Empirical relationship between functional group contribitions and melting points of C1-esters.
    Cho MJ; Morozowich W
    J Pharm Sci; 1979 Aug; 68(8):1069-71. PubMed ID: 480169
    [No Abstract]   [Full Text] [Related]  

  • 17. Syntheses of [11C]methyl esters of prostaglandins D2 and E2.
    Gullberg P; Watanabe Y; Svärd H; Hayaishi O; Långström B
    Int J Rad Appl Instrum A; 1987; 38(8):647-9. PubMed ID: 2822623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure activity studies leading to a tissue-selective hypotensive prostaglandin analog, 13,14-dihydro-16-phenyl-omega-tetranor PGE2.
    Johnson MR; Schaaf TK; Constantine JW; Hess HJ
    Prostaglandins; 1980 Sep; 20(3):515-20. PubMed ID: 7422897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins and congeners. 22. Synthesis of 11-substituted derivatives of 11-deoxyprostaglandins E1 and E2. Potential bronchodilators.
    Floyd MB; Schaub RE; Siuta GJ; Skotnicki JS; Grudzinskas CV; Weiss MJ; Dessy F; VanHumbeeck L
    J Med Chem; 1980 Aug; 23(8):903-13. PubMed ID: 7401116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ; McKechnie K
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.